PACIRA BIOSCIENCES IN

Pacira Announces FDA Approval of Enhanced EXPAREL Manufacturing Process

02 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

New Analysis Shows iovera° Plays a Critical Role in Achieving Significant Reductions in Opioid Use, Pain Scores, and Hospital Stay Following Total Knee Arthroplasty

29 Jul 2021 06:30:00 By Nasdaq GlobeNewswire

Pacira to Report Second Quarter 2021 Financial Results on Tuesday August 3, 2021

20 Jul 2021 06:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021

13 Jul 2021 07:00:03 By Nasdaq GlobeNewswire

Pacira Announces EXPAREL Distribution Agreement with Eurofarma in Latin America

22 Jun 2021 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021

08 Jun 2021 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Top-line Results from Phase 3 STRIDE Study Evaluating EXPAREL as a Lower Extremity Nerve Block

26 May 2021 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 Jefferies Virtual Healthcare Conference

25 May 2021 07:00:03 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Notice of Allowance of New Patent for EXPAREL

18 May 2021 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 RBC Capital Markets Global Healthcare Conference

12 May 2021 07:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $44.6 Million for April 2021

11 May 2021 07:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports First Quarter 2021 Financial Results and Business Update

04 May 2021 07:00:01 By Nasdaq GlobeNewswire

Pacira to Report First Quarter 2021 Financial Results on Tuesday May 4, 2021

21 Apr 2021 06:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Investment in Spine BioPharma

20 Apr 2021 06:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Seeks Court Injunction to Protect Clinical Integrity of EXPAREL in the Face of Scientifically Flawed and Misleading Information Published in Anesthesiology

14 Apr 2021 15:00:00 By Nasdaq GlobeNewswire

Pacira Reports Preliminary Net Product Sales of $118.7 Million for the First Quarter of 2021

07 Apr 2021 07:00:00 By Nasdaq GlobeNewswire

Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric Patients

22 Mar 2021 17:42:22 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021

09 Mar 2021 07:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference

03 Mar 2021 06:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results

25 Feb 2021 07:00:03 By Nasdaq GlobeNewswire